机译:玻璃体内AfliBercept和Ranibizumab型3型新生血管
Konyang Univ Myung Gok Eye Res Inst Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;
Konyang Univ Myung Gok Eye Res Inst Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;
Konyang Univ Myung Gok Eye Res Inst Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;
Konyang Univ Myung Gok Eye Res Inst Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;
Konyang Univ Myung Gok Eye Res Inst Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;
Konyang Univ Myung Gok Eye Res Inst Kims Eye Hosp Dept Ophthalmol Coll Med Seoul South Korea;
aflibercept; age-related macular degeneration; ranibizumab; Type 3 neovascularization; vascular endothelial growth factor;
机译:玻璃体内AfliBercept和Ranibizumab型3型新生血管
机译:Aflibibercept或Ranibizumab对近视脉络膜新生血管形成的胆管平或Ranibizumab的影响
机译:在观察研究中,用玻璃体内AFLIBERCEPT注射或RANIBIZIMAB治疗的患者的新脉络膜新生血管中的发病率
机译:Bevacizumab,AfliBelcept和Ranibizumab的即用效力效力测定
机译:玻璃体切除术完成后玻璃体内或肌腱下注射丙酮酸曲安奈德对增生性糖尿病性视网膜病变的眼睛周围脉络膜脉络膜厚度的影响
机译:玻璃体腔注射阿柏西普注射液对玻璃体腔注射兰尼单抗难治性视网膜色素上皮撕裂对老年性黄斑变性的影响
机译:玻璃体腔注射阿柏西普注射液对雷珠单抗注射后难治的视网膜色素上皮撕裂对老年性黄斑变性的影响